PepGen Therapeutics

PepGen Therapeutics

    Company info:

  • 1-50
  • 2018
  • Cambridge, MA
  • 100-500M

Claim company profile

About company:

PepGen Therapeutics is creating the next generation of oligonucleotide therapies to transform treatments of neuromuscular diseases. Oligonucleotides delivered into cells can modulate RNA expression to treat disease. PepGen is using their proprietary Enhanced Delivery Oligonucleotide (EDO) platform to identify cell-penetrating peptide conjugates that improve the activity and tolerability of oligonucleotide cargo therapeutics. PepGen’s proprietary EDO peptides are engineered for optimal tissue and cell penetration and have been shown to transport oligonucleotides into many target tissues including skeletal and cardiac muscle. PepGen is generating a pipeline of oligonucleotide therapies that target the root cause of serious neuromuscular diseases.


PepGen Therapeutics
Associate / Clinical Project Manager
Cambridge, MA|9 days ago
PepGen Therapeutics
Director, Investor Relations and Corporate Communi...
Cambridge, MA|13 days ago
PepGen Therapeutics
Senior Scientist, Drug Substance
Cambridge, MA|16 days ago
PepGen Therapeutics
Senior Manager, Program Management, Drug Developme...
Cambridge, MA|17 days ago
PepGen Therapeutics
Vice President, CMC Development
Cambridge, MA|100+ days ago
PepGen Therapeutics
Vice President Discovery Research
Cambridge, MA|100+ days ago

© 2023 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy